SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
NCT00117052
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
673
Enrollment
INDUSTRY
Sponsor class
Conditions
Secondary Hyperparathyroidism
End Stage Renal Disease
Interventions
DRUG:
cinacalcet
Sponsor
Amgen